• linkedin
  • Increase Font
  • Sharebar

    California team working to develop acne vaccine


    Next steps

    So far, Huang and his team have found promising results by testing the vaccine on skin biopsies collected from acne patients. They are now looking for pharmaceutical partners willing to help them conduct large-scale clinical trials. Huang said his hope is to have the vaccine ready for use within five years of the first clinical trial.

    While acne may be viewed as a cosmetic concern, it can have a huge impact on a patient’s psychosocial health, can lead to infection, and current treatments are very costly in terms of both financial cost and side effects.

    One U.K. study from 2015 revealed that requests for acne treatment jumped 214% in just one year, and that 35% of those requests were from patients over age 35. About 50 million people in the U.S. suffer from acne, and costs associated with treating the condition are $3 billion annually, according to the American Academy of Dermatology.

    Huang said. “We hope our preventive acne vaccine can prevent the occurrence of acne vulgaris and that our therapeutic acne vaccines can significantly and quickly reduce the inflammation of acne vulgaris without induction of development of drug-resistant P. acne bacteria—a frequent occurrence when acne vulgaris is treated with antibiotics.”

    Rachael Zimlich, RN
    Rachael Zimlich is a freelance writer in Cleveland, Ohio. She writes regularly for Contemporary Pediatrics, Managed Healthcare ...


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Latest Tweets Follow